Clinical Trial Update: Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines

View source ↗

Summary

This trial evaluated tiotropium (Spiriva) for its impact on the Activities of Daily Living score used in Austrian COPD guidelines. The study in chronic obstruct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Spiriva (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED | Results posted: 2009-12-24